Aspen's Acquisition of Sigma For APAC Expansion Comes At Time Of Generics Uncertainty In Australia
This article was originally published in PharmAsia News
Executive Summary
TOKYO - South African firm Aspen appears on track to finalize its months-long acquisition attempt of Australia's Sigma Pharmaceuticals, shifting away from its original offer for a full acquisition to a leaner deal in which Aspen will gain Sigma's pharmaceutical division